Overview

The Department of Science and Technology–Philippine Council for Health Research and Development (DOST-PCHRD), the University of Trieste (UniTS) and Fondazione Italiana Fegato (FIF) entered into an Agreement to develop and implement a program focused on molecular hepatology within the PhD Program in Molecular Biomedicine of UniTS. The three-year program integrates basic research and clinics focusing on the study of molecular approaches to cancer biology, genetics, jaundice, and metabolic diseases in the liver.

Applicant’s research interests must be aligned with the National Unified Health Research Agenda (NUHRA) and Harmonized National Research and Development Agenda (HNRDA).

Program Objectives

The PhD program aims to achieve the following objectives:

Develop a pool of high-quality human resources in molecular biomedicine (molecular hepatology in particular) who will contribute to the country’s global competitiveness and economic development;
Provide opportunities to deserving students to study and obtain PhD degrees in molecular biomedicine in reputable institution abroad;
Contribute to the country’s health research and technological innovation capabilities through training on biomedical research; and
Create the basis for a Filipino Liver Network integrating basic and clinical research in liaison with FIF.
Capacity

Two (2) positions for the PhD program are available each year at UniTS-FIF (subject to the availability of funds).

Eligibility

The applicant must:

be a Filipino citizen;
be in good health condition;
not be more than 50 years old at the time of application;
have a Master’s degree in a field relevant to health and biomedicine;
have an outstanding academic record;
have passed the admission requirements for the PhD study;
have passed the interview and other screening procedures;
not avail or enjoy any other scholarships; and
be willing to render the required service obligation for a period equivalent to twice the length of time or a fraction thereof that they enjoyed the PhD scholarship.
Scholarship Privileges

School fees (i.e. bench fees, permits, etc.)
Learning materials and/or connectivity allowance
Living/subsistence allowance
Health and accident insurance
One round-trip economy fare from residence to Italy (start and end of the scholarship period only)
Pre-departure allowance (one-time only)
Outright dissertation grant
SELECTION PROCEDURE

Scholarship Application The applicant must submit the necessary requirements for the Foreign Graduate Scholarship Program to DOST-PCHRD
Document Screening Documentary evaluation of the accomplished forms and other requirements
Technical interview and evaluation Technical interview by a panel composed of DOST-PCHRD Director, FIF Scientific Director, member(s) of the PhD program in molecular medicine of UniTS, and other health research experts to assess:
Academic background and learning ability
Capacity for completing the study in Italy
Possibility of contributing to the development of the country
Compatibility to the university course
Final Selection The panel will identify the successful PhD student(s) among the candidates interviewed.
Note: An applicant who has already started their studies abroad prior to application to the scholarship program can no longer apply.

2024 TIMELINE

February 1 Opening of the Call for Applications/Submission of Application
March 15 Application deadline
March (last week) In-person interview at PCHRD
April Final evaluation of PCHRD-UniTS-FIF selection committee
May Announcement of the accepted candidate(s)
June-September Preparation of necessary documents (visa, insurance, bank account, etc.) and signing of scholarship agreement
October Orientation of Scholars and Departure
November Start of PhD program
HOW TO APPLY

Please check the eligibility criteria in this Call before submitting your application. To signify interest in applying for the PhD scholarship program, applicants may submit their CVs on or before March 15, 2024 (Friday) through the online portal. Only eligible applicants will be entertained.

Eligible applicants will be asked to submit the following documents for the initial screening:

1) Application Form with recent ID pic

2) Re-Entry Action Plan

3) Certifications for all qualifications undertaken (i.e. Certificate of Master’s Degree)

4) Transcript of records (Certified true copy)

5) Endorsement letters from two (2) former professors in the MD/MS program

6) Certificate of employment (if employed, provide also a letter of recommendation and permission to take a leave of absence from employer or head of agency while on scholarship)

All documentary requirements must be submitted not later than March 20, 2024 (Wednesday).

For submission of documents and any other inquiries, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

In 2023, the DOST-PCHRD launched the HeaRT for the Filipino, an integrated marketing communications campaign which highlighted the role and contributions of health research and technology in making lives better for the Filipino people. 

This year the DOST-PCHRD will relaunch the “Capture the Heart in Health Research Photo Contest II,” a photo contest which will engage researchers who worked on or are currently working on PCHRD-supported research projects. Also, as a way to reach the general public, the team also aims to set a category that is open to everyone. The entries for the photo contest will be published on the Council’s official social media pages: Facebook and Twitter, as a way to increase awareness among the general public on health research initiatives.

At the end of the contest, individuals per category will be awarded and given a cash prize amounting to P10,000, P5,000, and P3,000. Special awards with a cash prize of P1,500 pesos will also be awarded as follows: People’s Choice and DOST-PCHRD Executive Director’s Choice.

CONTEST GUIDELINES

ELIGIBILITY

The contest is open to all project leaders and members whose research is supported by the DOST-PCHRD from 2017 to 2024. For the third category, the contest is open to all individuals, ages 18 years old above. Winning projects and entries in the 2023 Capture the Heart in Health Research Photo Contest are prohibited from joining the competition.  

Joining the contest is free of charge. Employees of PCHRD and members of their immediate family are not eligible to participate.

THEME: “HeaRT (Health Research and Technology) for the Filipino”

Entries for the photo contest should carry the theme: “HeaRT for the Filipino.” Specifically, they should highlight how initiatives on health research can make a difference towards the lives of the Filipino people.

The photo entry should be taken within the period of January to February 23, 2024. Participants may join in any of the three categories:

  1. For Ongoing Projects. The photo may focus on the research team in action, an event led under the project, or related research activities. The entry should come with a one to three sentence description that highlights how the photo portrays a heart for the Filipino people.
  2. For Completed Projects. The photo should highlight the outcome of the project conducted by the research team from 2017 – 2023. This should highlight research utilization, in any way applicable. The entry should come with a one to three sentence description that highlights how the photo portrays a heart for the Filipino people. 
  3.  For the General Public. The photo should depict Heart for the Filipino. This should highlight the 7Ms Filipino core values that are widely known for: Malikhain, Makatao, Makakalikasan, Makabansa, Masayahin, May Bayanihan, and May Pag-asa. The entry should come with a one to three sentence description that highlights how the photo portrays heart for the Filipino.

MECHANICS

  • All entries should be sent via email to This email address is being protected from spambots. You need JavaScript enabled to view it. from January 5 to February 26, 2024. Each project/individual (for category 3) is allowed to submit one (1) entry only. Participants should indicate the category number and the photo title in the subject line (Category 1 – Photo Title).
  • Upon submission of entries, the contestants certify the following:
      • They own the photographs submitted and they grant DOST-PCHRD full permission to use it in knowledge packaging, sharing, and advocacy related to DOST-PCHRD mandate. DOST-PCHRD  shall ensure that the owner of the photograph will be properly acknowledged for photos used, such as in print and digital publications.
      • The photographs are original, have not won any previous photo contests, have not been published elsewhere (whether print or electronic), and have not been submitted as entries to any other photo contests.
      • The photos have not been digitally altered and/or enhanced in any way other than simple cropping and minor adjustments on brightness, contrast, and saturation.
  • The entry to be submitted should be digital, colored, in JPEG format and at least 3,000 pixels wide for a horizontal image, or 3,000 pixels tall for a vertical image at 300 dpi.
  • The submitted entry should include the following details in English:
      • Full name of the owner of photograph: 
      • Current affiliated Institution and designation:
      • Project Title (from which PCHRD-supported project the photo was taken):
      • Project Duration:
      • Project Leader:
      • Photo title:
      • Photo caption for social media posting (1-3 sentences only):
      • Date when the photo was taken:
      • Place where the photo was taken:

Note: If the project member will submit the entry, the project leader should issue a certification that he or she is a team member of the project.

  • Awarding ceremonies will be held on 15 March 2024 during the 42nd Anniversary celebration of DOST-PCHRD. Winners will be notified via email.
  • Deadline of Submission: 26 February, 2024 5:00 P.M. The submission will automatically close and reject any entries that will be submitted after the deadline.
  • Eligible entries per category will be posted at the DOST-PCHRD Facebook Page for viewing and voting for the People’s Choice Award starting 1 March until 8 March 2024 at 5:00 p.m.
  • Announcement and awarding of winners : 15 March 2024

CRITERIA FOR JUDGING

Relevance to the Theme  –  40%

Impact (Communication potential of the photo) –  40%

Creativity of caption – 5%

Photo quality (sharpness color, contrast, pixels) – 15%

TOTAL    —————  100%

FOR QUESTIONS AND INQUIRIES:
Please contact Ms. Allyn I. Villahermosa at This email address is being protected from spambots. You need JavaScript enabled to view it.


The Cagayan Valley Health Research and Development Consortium (CVHRDC), in collaboration with the Medical Colleges of Northern Philippines, successfully concluded its informative Webinar Series today via Zoom entitled "Establishing the Ethical Character of Health Research Outputs: Emphasizing Accession to Various Ethics Clearances and Permits”.

Mr. Reynaldo M. Adducul of MCNP extends a warm welcome to all participants. In her opening message, Dr. Razel Nikka M. Hao, the Regional Director of DOH-02 and Co-chair of CVHRDC highlighted the need for continuous innovation and development of health research aimed at benefiting the public.
"Adhering to ethical guidelines, obtaining necessary approvals, and securing permits are crucial steps in our research journey that guarantee the reliability of our research results,” Dr. Hao stressed.

The webinar featured esteemed resource speakers who delivered expert presentations on securing Animal Permits, Gratuitous Permits, and Biosafety Clearances namely Mr. Dondon Adan S. Bait, Regional Animal Welfare Officer of the Department of Agriculture, Ms. Teresita P. Rivera, Senior Ecosystems Management Specialist of DENR, and Ms. Ruby S. Garcia, Focal Person, DOST-Biosafety Committee

The highlight of the webinar was the engaging open forum. The interactive session allowed attendees to seek clarification, share experiences, and gain a deeper understanding of the accession of health research permits.

Last January 19, 2024, Part 1 of the webinar was conducted with the topics on securing ethics Clearance and NCIP Inform Consent Form.

The CVHRDC under the DOST-02 led by Dir. Virginia G. Bilgera, remains committed to advancing research initiatives and providing valuable platforms for knowledge dissemination. Thus, the success of the webinar series underscores the consortium's dedication to enhancing ethical standards in health research for the greater benefit of the public.

#cvhrdc
 
May be an image of 6 people, people smiling, eyeglasses and text
May be an image of 1 person and text
May be an image of 1 person and text
May be an image of 1 person and text
 

The Department of Science and Technology Regional Office No. II (DOST II) through the Cagayan Valley Health Research and Development Consortium (CVHRDC) in collaboration with the Medical Colleges of Northern Philippines (MCNP) successfully conducted part 1 of Establishing the Ethical Character of Health Research Outputs: Emphasizing Accession to Various Clearances and Permits via Zoom and Facebook Live.
 
The Webinar started with President Christian R. Guzman, MCNP, Welcome Remarks, and Dr. Virginia G. Bilgera, Regional Director DOST II, delivered by Dr. Julius T. Capili, CVHRDC Executive Director on January 19, 2023, via Zoom.
 
The primary objective of this webinar was to empower researchers, healthcare professionals, and stakeholders with essential knowledge. By emphasizing the importance of compliance with ethical, legal, and regulatory standards in health research, we aim to create a more robust and ethical research environment.
 
The National Commission on Indigenous Peoples (NCIP) Ilagan Community Service Center, Mr. Arnold M. Preza, discussed the importance and the process of issuance of Free, Prior, and Informed Consent (FPIC) and Indigenous Knowledge Systems and Practices (IKSP) before conducting any research project involving indigenous people (IPs)
 
On the other side, Dr. Josel Padolino Jr., a Regular Member of the Research Ethics Committee of Southern Isabela Medical Center, discussed how to get an Ethics Clearance and the different levels of PHREB Level Accredit Review Ethics Board.
 
We are truly grateful for the overwhelming response, with 500 attendees via Zoom and 83 attendees via Facebook Live joining us for this enlightening session.
The success of this webinar lies not only in the numbers but also in creating a community that is now better equipped to champion ethical research.
A heartfelt thank you to our distinguished speakers, engaged participants, and everyone who contributed to the success of this webinar.
 
See you on January 26 for the Part 02 of this webinar series!
 
May be a graphic of text that says '1 CYHRDG Department of Science and Technology Regional Office II Cagayan Valley Health Research and Development Consortium collaboration with Medical Colleges of Northern Philippines Free Webinar on ESTABLISHING THE ETHICAL CHARACTER OF HEALTH RESEARCH OUTPUTS: "Emphasizing Accession to Various Ethics Clearances and Permits" January 19,26, 2024 via Zoom'
May be an image of 2 people and text that says 'Recording.. EN Youar viewing CVHRDC_ enny-R Masocol's screen View Options MEDICAL COLLEGES OF NORTHERN PH' INTERNATIONAL SCHOOL ASIA AND Welcome Remarks DR. CHRISTIAN GUZMAN President, MCNP COLEGES NORTHER PODSEN *1994* ISAP 1997 CAGAYAN VALLEY HEALTH RESEARCH AND DEVELOPMENT CONSORTIUM f facebook.com/rcvhrdc <span id=This email address is being protected from spambots. You need JavaScript enabled to view it.'" />
May be an image of 2 people and text
May be an image of 16 people and text
May be an image of 18 people and text

CALL FOR NOMINATIONS: 2024 ALBERTO G. ROMUALDEZ, JR. OUTSTANDING HEALTH RESEARCH AWARD (AROHRA)

The Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD) is pleased to announce that the Call for Nominations for the 2024 Alberto G. Romualdez, Jr. Outstanding Health Research Award (AROHRA) is now open.

The Alberto G. Romualdez, Jr. Outstanding Health Research Award (AROHRA), given every three years, encourages researchers to be sensitive to the scientific and technological needs of the health delivery system and rewards those whose research have contributed significantly to addressing prevalent health issues.

The Award seeks to commend research programs or projects that have demonstrated strong link between research and practice through the utilization of research findings in the health delivery system. Given by the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) in collaboration with other implementing agencies of the Philippine National Health Research System (PNHRS), the Award has two (2) categories, namely: Biomedical Research and Health Services Research.

ELIGIBILITY

1. What can be nominated

The award is open to completed research programs or projects done or led by Filipino researcher/s. The nominated entry must be done mainly in the Philippines or that its scope, participants and beneficiaries are in the Philippines. 

For purposes of this Award, a research program refers to a group of interrelated or complementing research projects that require an interdisciplinary or multidisciplinary approach to meet established goal/s within a specific time frame, while a research project refers to the basic unit in the investigation of specific research problems with predetermined objective/s to be accomplished within a specific time frame.

Nominated research programs or projects may fall under any of two categories: Biomedical Research or Health Services Research.

  • For Biomedical Research, the program or project must be engaged in generating and/or adopting appropriate health technologies that address specific health problems and emphasize the development of diagnostic tools and techniques, biologicals (e.g. drugs, vaccines, functional foods, etc.), biomedical devices, and ICT-based healthcare technologies.
  • For Health Services Research, the program or project must be involved in the organization, administration, operation, utilization and other aspects of health services delivery systems that address the country’s social, political, cultural, and economic conditions.

2. Who can nominate

Any institution; members of the consortium; scientific, technological and professional societies or associations; research institutes; universities and colleges; and individuals may submit a nomination. Self-nomination is not allowed.

NOMINATION PROCEDURES

Submit the AROHRA nomination form (guide questions) for initial screening to the Regional Health Research and Development Consortium (RHRDC) Secretariat. Nominations must be received by the RHRDC secretariat no later than January 5, 2024.

You may find the nomination form, guide questions, guidelines, and RHRDC directory at this link: https://bit.ly/2024AROHRANominationForm

Shortlisted nominees will be endorsed by the RHRDCs to DOST-PCHRD. Qualified nominees will be selected and contacted by DOST-PCHRD. Qualified nominees will be required to submit the following documents in hard and electronic copies:

  1. Fully-accomplished Entry Form
  2. Write-up on the impact of the project on health delivery, a contextualization of the problem that the program/project seeks to address and a description of the program/project, highlighting how the results were utilized, as well as the benefits derived from their utilization.
  3. One copy of each of the technical reports and/or publications of the completed projects leading to technology transfer and/or translation to a policy formulation or program intervention.
  4. Statement from the technology user(s) and program or project end-user(s) describing the contribution of the technology and program or project in improving health delivery.

After the preliminary screening, the judges may ask for additional supporting documents from the nominees.

SELECTION

1. Criteria for Selection

Criteria for selection will vary according to category.

    1. Biomedical Research

a.1 Extent of impact on health/quality of life – 50%

    • Contributes to the promotion of well-being of a significant section of the population – the technology developed or adopted must have addressed any of the top ten diseases/causes of morbidity/mortality in the Philippines or within the National Objectives for Health (NOH)/Sustainable Development Goals(SDGs)/ AmBisyon Natin 2040 (25%)
    • Designed towards a long-term solution to health problems affecting a majority of the population – the technology developed or adopted must be geared towards reduction in the incidence/prevalence of disease or the burden of disease (15%)
    • Addresses a health priority or commitment aligned with the National Unified Health Research Agenda (NUHRA) (5%)
    • Has short gestation period for timely application of results (the duration of development and application fall within 3 years) or can present interim results that are substantial and impactful (5%)

a.2 Economic benefits – 30%

    • Has potential savings accruing from import substitution and reduced healthcare costs (cost benefit derived from the use and application of the product or process generated by the research program or project) (15%)
    • Has a potential for export (Applications for quality assurance certification and patent registration have been filed to ensure that the product is safe and commercially viable) (5%)
    • Increases productivity and generates employment (based on a potential technology commercialization plan or proof of commercial initiation or an intent for commercial application e.g. medicinal product has generated work for Filipino farmers) (5%)
    • Achieves better allocation/application of health resources (The technology generated by the research program or project uses locally sourced materials or if it is a process, has sourced its experts from within the local expert community, which includes local manufacturing plants and experts from local engineers/technicians, if applicable)  (5%)

a.3 S&T benefits – 20%

    • Contributes to the existing body of knowledge and/or provides a solution or technological innovation regarding a health problem (15%)
    • Serves as a stepping stone for other areas of investigation (with impact on knowledge generation) (5%)

b. Health Services Research

b.1 Extent of impact on health/quality of life – 60%

    • Contributes to the promotion of well-being of a significant section of the population (the operational nature/extent of the health services problem addressed any of the top ten diseases/causes of morbidity/mortality in the Philippines or within the National Objectives for Health (NOH)/Sustainable Development Goals(SDGs)/ AmBisyon Natin 2040 (20%)
    • Designed towards a long-term solution to health problems affecting a majority of the population especially in the geographically isolated and disadvantaged areas – (the project’s operation or administration is geared towards or has brought about a solution to an administrative/operational/utilization problem concerning a health service/disease or situation)1 (30%)
    • Addresses a health priority or commitment aligned with the National Unified Health Research Agenda (NUHRA) (5%)
    • Has a short gestation period for timely application of results (the realizable gain must have been documented and/or attested by the program manager/s of DOH within 3 years of project implementation) or can present interim results that are substantial and impactful (5%)

b.2 Economic benefits – 30%

    • Has potential savings accruing from reduced healthcare cost (cost benefit or utilization cost derived from the organizational/ administrative/operational change) (15%)
    • Increases human resource productivity (the aspect of human resources for health that translates into productivity as a result of the organizational involvement of the project with existing health programs) (10%)
    • Achieves better allocation/application of health resources (the changes introduced by the research program or project provides savings or the streamlining of services, procurement systems, or other processes, which results in better health services) (5%)

b.3 S&T benefits – 10%

    • Contributes to the existing body of knowledge and/or provides a solution to health problems (the managerial/operational issue on services being resolved) (5%)
    • Serves as a stepping stone for other areas of investigation (the ability of the project to generate research questions that will further improve health services) (5%)

2. Procedure for Selection

a. There will be two (2) levels of selection: Preliminary Screening and Final Selection

b. Preliminary Screening:

b.1 Nominations for the Award will be evaluated by a Screening Committee composed of distinguished scientists and technical experts appointed by the DOST-PCHRD. The Screening Committee can undertake visits or interview nominees or other concerned individuals to validate statements made in the entry form.

b.2 The Screening Committee recommends a shortlist of candidates to the Board of Judges for its consideration.

c. Final Selection:

c.1 The Board of Judges reviews the work of short-listed candidates and decides on the awardee for each category based on the set criteria.

c.2 If the Board of Judges finds that no research program or project sufficiently meets the qualifications for a particular category, the Board of Judges has the prerogative to not grant the Award. Winners are ineligible for subsequent nominations, while non-winners are still eligible for nominations upon submission of a new set of documents.

c.3 The decision of the Board of Judges is final.

INCENTIVES

The winners in each category will receive a cash prize amounting to PHP 1,000,000.00 (Net of Tax) and a trophy. Consolation prizes amounting to PHP 30,000.00 (Net of Tax) will also be provided to the shortlisted nominees.

TIMETABLE

Activities Schedule
Call for nominations November – December 2023
Deadline of submission of recommendation form to respective consortium January 5, 2024
Submission of the endorsed recommendation forms to DOST-PCHRD January 12, 2024
Submission of complete nominees’ documents to DOST-PCHRD February – March 2024
Screening of nominees’ submitted documents March – April 2024
Selection Process May – June 2024
Awarding PNHRS Week Celebration 2024

 

(2nd week of August)

 


The general areas that can be considered are as follows:

  • Decision based solution to operational problems, e.g., Clinical Practice Guidelines that significantly reduce mortality/morbidity
  • Improvement of the value chain in the healthcare system in terms of services or product delivery, e.g., procedures that provide quality assurance in the cold chain of EPI that preserve vaccine integrity and potency
  • Application of qualitative/quantitative research results in operationalizing efficiency in the current health programs of the DOH, e.g., DOTS, Mass drug treatment in schistosomiasis, filariasis, geohelminths, as well as operational solution to reduce drug resistant malaria
  • A health technology adoption for which managerial/operational solutions were done or implemented to facilitate the adoption
  • A health technology adoption for which cultural/political/social changes have been done or implemented to facilitate the adoption

Subcategories

Featured Links

PNHRS

http://www.healthresearch.ph

PCHRD

http://www.pchrd.dost.gov.ph

eHealth

http://www.ehealth.ph

Ethics

http://ethics.healthresearch.ph

ASEAN-NDI

http://www.asean-ndi.org

Events Calendar

April 2025
S M T W T F S
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3